Cytomx Therapeutics Stock Analysis

CytomX Stock Analysis Notes

About 64.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California. Cytomx Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 174 people. For more info on CytomX Therapeutics please contact Sean DPHIL at 650 515 3185 or go to https://www.cytomx.com.

CytomX Therapeutics Investment Alerts

CytomX Therapeutics Upcoming and Recent Events

CytomX Largest EPS Surprises

View All Earnings Estimates

CytomX Therapeutics Thematic Classifications

CytomX Stock Institutional Investors

Note, although CytomX Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CytomX Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 68.48 M.

CytomX Profitablity

The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.

Management Efficiency

CytomX Therapeutics has return on total asset (ROA) of 0.0233 % which means that it generated a profit of $0.0233 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (54.7503) %, meaning that it created substantial loss on money invested by shareholders. CytomX Therapeutics' management efficiency ratios could be used to measure how well CytomX Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 0.01 in 2025, whereas Return On Tangible Assets are likely to drop (0) in 2025. At this time, CytomX Therapeutics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 945 K in 2025, whereas Non Current Assets Total are likely to drop slightly above 19.5 M in 2025.

Technical Drivers

As of the 31st of January, CytomX Therapeutics shows the Standard Deviation of 4.68, mean deviation of 3.64, and Risk Adjusted Performance of (0.03). CytomX Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CytomX Therapeutics Price Movement Analysis

CytomX Therapeutics Insider Trading Activities

CytomX Therapeutics Outstanding Bonds

CytomX Therapeutics Predictive Daily Indicators

CytomX Therapeutics Forecast Models

CytomX Therapeutics' time-series forecasting models are one of many CytomX Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CytomX Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how CytomX Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CytomX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CytomX Therapeutics. By using and applying CytomX Stock analysis, traders can create a robust methodology for identifying CytomX entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CytomX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CytomX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

CytomX Therapeutics stock analysis indicators help investors evaluate how CytomX Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CytomX Therapeutics shares will generate the highest return on investment. By understating and applying CytomX Therapeutics stock analysis, traders can identify CytomX Therapeutics position entry and exit signals to maximize returns.

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.